Showing results (81-90 of 99) with videos related to
Sort By:
Pageof 10
Immuno-Oncology Technology|June 27, 2022
Computational cancer neoantigen prediction: current status and recent advancesG Fotakis, Z Trajanoski, D RiederImmuno-Oncology Technology|March 20, 2023
Autoantibodies involved in primary and secondary adrenal insufficiency following treatment with immune checkpoint inhibitorsN C Helderman, M W Lucas, C U BlankImmuno-Oncology Technology|August 15, 2022
Effective generation of tumor-infiltrating lymphocyte products from metastatic non-small-cell lung cancer (NSCLC) lesions irrespective of location and previous treatmentsS M Castenmiller, R de Groot, A Guislain, et al.Immuno-Oncology Technology|March 18, 2025
The MELimmune score-prognostic factors for overall survival in advanced melanoma and anti-PD-1 monotherapy-a multicentre, retrospective cohort studyS Lobo-Martins, D Martins-Branco, P M Semedo, et al.Immuno-Oncology Technology|September 2, 2024
An organotypic human melanoma-in-skin model as an in vitro tool for testing Vγ9Vδ2-T cell-based immunotherapyE Michielon, L A King, T Waaijman, et al.Immuno-Oncology Technology|January 23, 2026
Safety and feasibility of blood-derived multiple antigen-specific endogenously derived T cells (MASE-T) for metastatic melanomaT J Monberg, S A Tvingsholm, M Svensson-Frej, et al.Immuno-Oncology Technology|January 22, 2026
Adjuvant anti-PD-1 therapy in high-risk cutaneous squamous-cell carcinoma: post hoc insights from the C-POST and KEYNOTE-630 studiesS Cavalieri, A Ottini, C Bergamini, et al.Immuno-Oncology Technology|January 8, 2026
Refractory microsatellite-stable metastatic colorectal cancer: a comparison between botensilimab + balstilimab and current standard of careE Bengala, D Santini, V PiconeImmuno-Oncology Technology|November 17, 2025
Harnessing TCR repertoires: predictive insights and therapeutic monitoring in cancer immunotherapyJ Chiffelle, R Genolet, O Michielin, et al.Immuno-Oncology Technology|December 23, 2024
Armoring chimeric antigen receptor (CAR) T cells as micropharmacies for cancer therapyC Carcopino, E Erdogan, M Henrich, et al.Pageof 10